Model‐Informed Precision Dosing Guidance of Ethosuximide Developed from a Randomized Controlled Clinical Trial of Childhood Absence Epilepsy

乙磺酰亚胺 加药 医学 人口 随机对照试验 丙戊酸 癫痫 拉莫三嗪 不利影响 药代动力学 麻醉 内科学 抗惊厥药 精神科 环境卫生
作者
Kana Mizuno,Edmund V. Capparelli,Tsuyoshi Fukuda,Min Dong,Peter C. Adamson,J Blumer,Avital Cnaan,Peggy O. Clark,Michael D. Reed,Shlomo Shinnar,Alexander A. Vinks,Tracy A. Glauser
出处
期刊:Clinical Pharmacology & Therapeutics [Wiley]
卷期号:114 (2): 459-469 被引量:1
标识
DOI:10.1002/cpt.2965
摘要

Ethosuximide was identified as the optimal option for new-onset childhood absence epilepsy (CAE) in a randomized, two-phase dose escalation comparative effectiveness trial of ethosuximide, lamotrigine, and valproic acid. However, 47% of ethosuximide initial monotherapy participants experienced short-term treatment failure. This study aimed to characterize the initial monotherapy ethosuximide exposure-response relationship and to propose model-informed precision dosing guidance. Dose titration occurred over a 16-20-week period until patients experienced seizure freedom or intolerable side effects. Subjects with initial monotherapy failure were randomized to one of the other two medications and dose escalation was repeated. A population pharmacokinetic model was created using plasma concentration data (n = 1,320), collected at 4-week intervals from 211 unique participants during both the initial and second monotherapy phases. A logistic regression analysis was performed on the initial monotherapy cohort (n = 103) with complete exposure-response data. Eighty-four participants achieved seizure freedom with a wide range of ethosuximide area under the curves (AUC) ranging from 420 to 2,420 μg·h/mL. AUC exposure estimates for achieving a 50% and 75% probability of seizure freedom were 1,027 and 1,489 μg·h/mL, respectively, whereas the corresponding cumulative frequency of intolerable adverse events was 11% and 16%. Monte Carlo Simulation indicated a daily dose of 40 and 55 mg/kg to achieve 50% and 75% probability of seizure freedom in the overall population, respectively. We identified the need for adjusted mg/kg dosing in different body weight cohorts. This ethosuximide proposed model-informed precision dosing guidance to achieve seizure freedom carries promise to optimize initial monotherapy success for patients with CAE.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
俏皮诺言完成签到,获得积分10
5秒前
夏夏完成签到,获得积分20
14秒前
氮化硼小兵完成签到,获得积分10
14秒前
拾壹完成签到,获得积分10
15秒前
友好语风完成签到,获得积分10
16秒前
酷酷依秋完成签到,获得积分10
16秒前
liu完成签到 ,获得积分10
17秒前
土豆完成签到,获得积分10
18秒前
Lanny完成签到 ,获得积分10
20秒前
ooa4321完成签到,获得积分10
21秒前
21秒前
CLTTTt完成签到,获得积分10
22秒前
drizzling完成签到,获得积分10
23秒前
曦夜完成签到,获得积分10
24秒前
小二郎应助Tin采纳,获得10
26秒前
愛愛愛愛发布了新的文献求助10
26秒前
桃花源的瓶起子完成签到 ,获得积分10
28秒前
楚寅完成签到 ,获得积分10
29秒前
Yang完成签到 ,获得积分10
31秒前
丫头完成签到 ,获得积分10
31秒前
耿教授完成签到,获得积分20
33秒前
33秒前
狂野未来完成签到,获得积分10
36秒前
phoenix001完成签到,获得积分0
39秒前
七米日光完成签到 ,获得积分10
39秒前
chaosyw完成签到,获得积分10
39秒前
故意的问安完成签到 ,获得积分10
41秒前
仗炮由纪完成签到,获得积分10
45秒前
笑一笑完成签到 ,获得积分10
46秒前
仗炮由纪发布了新的文献求助20
48秒前
费城青年完成签到,获得积分10
49秒前
perway完成签到,获得积分20
49秒前
隐形曼青应助瞿寒采纳,获得10
50秒前
lxlcx完成签到,获得积分0
53秒前
研友_VZGVzn完成签到,获得积分10
57秒前
58秒前
1分钟前
瞿寒发布了新的文献求助10
1分钟前
Tin完成签到,获得积分10
1分钟前
愛愛愛愛完成签到,获得积分10
1分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968578
求助须知:如何正确求助?哪些是违规求助? 3513391
关于积分的说明 11167428
捐赠科研通 3248822
什么是DOI,文献DOI怎么找? 1794499
邀请新用户注册赠送积分活动 875116
科研通“疑难数据库(出版商)”最低求助积分说明 804664